Evidence map›Paper›PMID 17641018›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2007

Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.

Adam T Hagymasi, Aaron M Slaiby, Marianne A Mihalyo, Harry Z Qui, David J Zammit, Leo Lefrancois, Adam J Adler

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2011
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adam T HagymasiCenter for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut Health Center, Farmington, CT 06030, USA.
Aaron M Slaiby
Marianne A Mihalyo
Harry Z Qui
David J Zammit
Leo Lefrancois
Adam J Adler
UConn Health · US

Funding

Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced CostimulationR01CA109339 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ADLER, ADAM J, VELLA, ANTHONY T · 2004 to 2015
$2.9M
Mechanisms of Effector CD4 Cell TolerizationR01AI057441 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ADLER, ADAM J · 2004 to 2008
$1.6M
Mechanisms of Effector CD4 Cell TolerizationR56AI057441 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ADLER, ADAM J · 2009 to 2009
$383k
NCI NIH HHS CA109339NCI NIH HHS R01 CA109339NIAID NIH HHS AI057441NIAID NIH HHS R01 AI057441NIAID NIH HHS R56 AI057441
6 · The paper itself

Abstract

Bone marrow-derived APC are critical for both priming effector/memory T cell responses to pathogens and inducing peripheral tolerance in self-reactive T cells. In particular, dendritic cells (DC) can acquire peripheral self-Ags under steady state conditions and are thought to present them to cognate T cells in a default tolerogenic manner, whereas exposure to pathogen-associated inflammatory mediators during the acquisition of pathogen-derived Ags appears to reprogram DCs to prime effector and memory T cell function. Recent studies have confirmed the critical role of DCs in priming CD8 cell effector responses to certain pathogens, although the necessity of steady state DCs in programming T cell tolerance to peripheral self-Ags has not been directly tested. In the current study, the role of steady state DCs in programming self-reactive CD4 cell peripheral tolerance was assessed by combining the CD11c-diphtheria toxin receptor transgenic system, in which DC can be depleted via treatment with diphtheria toxin, with a TCR-transgenic adoptive transfer system in which either naive or Th1 effector CD4 cells are induced to undergo tolerization after exposure to cognate parenchymally derived self-Ag. Although steady state DCs present parenchymal self-Ag and contribute to the tolerization of cognate naive and Th1 effector CD4 cells, they are not essential, indicating the involvement of a non-DC tolerogenic APC population(s). Tolerogenic APCs, however, do not require the cooperation of CD4(+)CD25(+) regulatory T cells. Similarly, DC were required for maximal priming of naive CD4 cells to vaccinia viral-Ag, but priming could still occur in the absence of DC.

Indexed as

Immune ToleranceAnimalsAntigen PresentationAutoantigensDendritic CellsHemagglutinin Glycoproteins, Influenza VirusMiceMice, Inbred C57BLMice, TransgenicResting Phase, Cell CycleTh1 CellsT-Lymphocytes, RegulatoryAutoantigensHemagglutinin Glycoproteins, Influenza Virus

Identifiers

PMID17641018
PMCPMC2846358
OpenAlexW1498481623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.